glp 1 and cancer GLP-1 Receptor Agonists: Benefits Risks in Colorectal GLP-1 receptors (GLP-1R) are expressed

GLP-1 receptor agonists like semaglutide have been examined through large-scale, randomized, placebo-controlled clinical trials involving thousands of participants

When a patient returns to their former weight, they add back fat mass but may also replace some of previously lost muscle mass with fat as well

The referral follows a public dispute between Novo Nordisk and the sale of compounded drugs marketed as alternatives to FDA-approved GLP-1 weight-loss medications, such as Wegovy

As a result, they offer benefits that extend beyond glycemic control

Both diarrhea and constipation are common, with diarrhea generally reported more frequently (830% of patients) compared to constipation (324%)

A fourth pattern is maintenance anxiety